These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 6189937

  • 1. Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.
    Mills CD, North RJ.
    J Exp Med; 1983 May 01; 157(5):1448-60. PubMed ID: 6189937
    [Abstract] [Full Text] [Related]

  • 2. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES.
    J Immunol; 1986 Feb 15; 136(4):1510-5. PubMed ID: 3080526
    [Abstract] [Full Text] [Related]

  • 3. Ly-1+2- suppressor T cells inhibit the expression of passively transferred antitumor immunity by suppressing the generation of cytolytic T cells.
    Mills CD, North RJ.
    Transplantation; 1985 Feb 15; 39(2):202-8. PubMed ID: 3155882
    [Abstract] [Full Text] [Related]

  • 4. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.
    Dye ES, North RJ.
    J Leukoc Biol; 1984 Jul 15; 36(1):27-37. PubMed ID: 6234371
    [Abstract] [Full Text] [Related]

  • 5. Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma.
    North RJ, Dye ES.
    Immunology; 1985 Jan 15; 54(1):47-56. PubMed ID: 3156088
    [Abstract] [Full Text] [Related]

  • 6. Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.
    Dye ES, North RJ.
    Transplantation; 1984 Jun 15; 37(6):600-5. PubMed ID: 6427998
    [Abstract] [Full Text] [Related]

  • 7. T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.
    Dye ES, North RJ.
    J Exp Med; 1981 Oct 01; 154(4):1033-42. PubMed ID: 6457075
    [Abstract] [Full Text] [Related]

  • 8. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.
    North RJ, Bursuker I.
    J Exp Med; 1984 May 01; 159(5):1295-311. PubMed ID: 6232335
    [Abstract] [Full Text] [Related]

  • 9. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD.
    Cancer Res; 1986 Apr 01; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [Abstract] [Full Text] [Related]

  • 10. Failure of specific adoptive immunotherapy owing to survival and outgrowth of variant cells.
    Hines DL.
    Cancer Immunol Immunother; 1989 Apr 01; 28(4):241-7. PubMed ID: 2495177
    [Abstract] [Full Text] [Related]

  • 11. In vitro expression of secondary antitumor immunity by in vitro tumor-sensitized T cells: inhibition by tumor-induced suppressor T cells.
    Kaymakcalan Z, Spitalny GL, Bursuker I.
    Cancer Immunol Immunother; 1987 Apr 01; 25(2):69-74. PubMed ID: 2959361
    [Abstract] [Full Text] [Related]

  • 12. T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity.
    DiGiacomo A, North RJ.
    J Exp Med; 1986 Oct 01; 164(4):1179-92. PubMed ID: 2944983
    [Abstract] [Full Text] [Related]

  • 13. The antimetastatic function of concomitant antitumor immunity. I. Host Ly-1+2+ effector T cells prevent the enumeration of metastatic tumor cells in a biological assay.
    Dye SE.
    J Immunol; 1986 Feb 15; 136(4):1504-9. PubMed ID: 3080525
    [Abstract] [Full Text] [Related]

  • 14. Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.
    Shu S, Rosenberg SA.
    J Immunol; 1985 Oct 15; 135(4):2895-903. PubMed ID: 2411817
    [Abstract] [Full Text] [Related]

  • 15. Adoptive immunotherapy of established tumors. Acquisition of radioresistance by tumor-specific T cells after passive transfer into tumor-bearing recipients.
    Dunn PL, North RJ.
    Int J Cancer; 1994 May 15; 57(4):592-7. PubMed ID: 8181862
    [Abstract] [Full Text] [Related]

  • 16. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.
    Uyttenhove C, Maryanski J, Boon T.
    J Exp Med; 1983 Mar 01; 157(3):1040-52. PubMed ID: 6187879
    [Abstract] [Full Text] [Related]

  • 17. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ, Yang J, Shu S, Rosenberg SA.
    J Immunol; 1986 May 15; 136(10):3899-909. PubMed ID: 2871106
    [Abstract] [Full Text] [Related]

  • 18. Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells.
    North RJ.
    Cancer Immunol Immunother; 1984 May 15; 16(3):175-81. PubMed ID: 6231095
    [Abstract] [Full Text] [Related]

  • 19. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD.
    Eur J Immunol; 1987 Feb 15; 17(2):173-8. PubMed ID: 3030766
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
    Lee FH, Currie D, Hwang KM.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5491-8. PubMed ID: 6208997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.